Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, December 1999, p. 2939-2942, Vol. 43, No. 12
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
A New Method for Assessing Metronidazole
Susceptibility of Giardia lamblia Trophozoites
M. Céu
Sousa* and
J.
Poiares-da-Silva
Laboratório de Microbiologia e
Parasitologia and Centro de Estudos Farmacêuticos da Faculdade de
Farmácia da Universidade de Coimbra, 3030 Coimbra, Portugal
Received 18 June 1999/Returned for modification 20 July
1999/Accepted 2 October 1999
 |
ABSTRACT |
A quantitative, simple, and rapid assay has been developed to
assess Giardia lamblia trophozoite sensitivity to
metronidazole [1-(2-hydroxyetyl)-2-methyl-5-nitroimidazole] (MTZ).
This new assay utilizes the ability of live (surviving) trophozoites to take up oxygen after have been exposed to MTZ. The effect of MTZ on
oxygen uptake was compared with its effect on viability as evaluated by
a culture method and morphological assays. Oxygen uptake rates
decreased in trophozoites treated with MTZ, and this effect was drug
concentration dependent: O2 uptake rates went from 3.04 µM O2 min
1 per 106 cells to
0.72 µM O2 min
1 per 106 cells
with increasing drug concentration (0.15 to 0.6 mM) in the
preincubation. Concentrations of the drug which inhibited oxygen uptake
by 28 to 76% in trophozoites killed from 39 to 82% of trophozoites,
as evaluated by the culture method, and altered the morphology of 21 to
86% of the trophozoites. Thus, the trophozoites killed by MTZ are
nonmotile cells and do not take up oxygen. A good correlation was found
between the inhibitory effects of MTZ, as evaluated by oxygen uptake,
and cellular viability. Similar 50% inhibitory concentrations were
obtained: 0.33 mM by oxygen uptake, 0.26 mM by the culture method, and
0.35 mM by morphological criteria. Oxygen uptake appears to be a good
indicator of parasite viability. Therefore, this new method can provide
a convenient means to assess MTZ susceptibility in G. lamblia and can be applied for screening potential antigiardial agents.
 |
INTRODUCTION |
Giardia lamblia is a
binucleated flagellar protozoan that causes intestinal infection in
humans. This parasite is endemic throughout the world, and it is the
most common isolated enteric pathogenic in Portugal. A striking feature
of giardiasis is the wide variability of the clinical symptoms.
Giardiasis may be entirely asymptomatic, may produce a mild
self-limiting illness, or may produce chronic diarrhea with or without
malabsorption. Although various drugs have been available for several
decades to treat this infection, none of them is entirely satisfactory
due to a high incidence of undesirable side effects and a significant
failure rate in clearing parasites from the gastrointestinal tract
(15, 19). Some evidence suggests that drug resistance may be
responsible for these failures (1, 15, 16).
Previously published methods for the assessment of antigiardial
activity in vitro rely on the viability of G. lamblia
trophozoites. However, in vitro drug studies have been hampered by the
lack of a good method for determining G. lamblia viability.
The morphological assay (13), inhibition of clonal growth
(8), culture (10), inhibition of radiolabelled
substrate incorporation (11), and adherence studies (2,
6, 9) offer some problems. Problems with morphological assays may
include the underestimation of parasite death if cells remain
morphologically intact, although they are actually unable to replicate.
The clonal growth method has low efficiency, regrowth and adherence
studies are time-consuming, and other methods require the use of
radiolabelled materials. Thus, considering the problems with in vitro
susceptibility tests and the clinical and epidemiological relevance of
drug resistance, the aim of this work was to evaluate a new method for
assessing drug susceptibility in G. lamblia.
G. lamblia is an aerotolerant organism. When exposed to
oxygen, it takes up oxygen at rates comparable to those of aerobic protozoa (12). The ability of G. lamblia NADH
oxidase to use O2 as an electron acceptor under aerobic
conditions explains the apparent respiration of the amitochondrial
fermentative metabolism of Giardia (3). Paget et
al. have also described that metronidazole (MTZ) inhibits the
O2 uptake of G. lamblia trophozoites and that oxygen uptake can be correlated with metabolic function
(17).
These findings prompted us to compare the in vitro effects of MTZ on
oxygen uptake and viability of G. lamblia trophozoites to
evaluate the eventual use of O2 uptake as an index of
viability. Oxygen uptake was measured with a Clark-type oxygen
electrode and was compared with the trophozoites' viability as
determined by the culture method and morphological criteria. The
G. lamblia strain WB (ATCC 30957) was used as a cellular model.
 |
MATERIALS AND METHODS |
Antimicrobial agent.
MTZ
[1-(2-hydroxyetyl)-2-methyl-5-nitroimidazole] was obtained from Sigma
Chemical Corporation. Fresh stock solutions of 4.8 mM were prepared by
dissolving pure MTZ in phosphate-buffered saline (PBS; 8 mM; pH 7.1).
Parasites and cultures.
G. lamblia (WB strain [ATCC
30957] originally from a patient with chronic diarrhea) was obtained
from the American Type Culture Collection, Rockville, Md. Trophozoites
were maintained in axenic culture at 37°C in 10 ml of Diamond's
TYI-S-33 medium, as modified by Keister (14), in screw-cap
cell culture vials. Penicillin G (250 µg/ml), streptomycin sulfate
(250 µg/ml), gentamicin sulfate (50 µg/ml), and amphotericin B
(0.25 µg/ml) were added during routine culture. After 2 days, the
cultures were harvested by cooling of the culture vials at 4°C for 15 min and centrifugation at 400 × g for 10 min. Trophozoites
were washed three times in PBS (8 mM; pH 7.1), and cells were counted
in a hemocytometer (Neubauer cell-counter chamber). These cells were
used as the inoculum with which to study the effects of MTZ on G. lamblia trophozoites.
Test procedure.
An inoculum of 4.5 × 106
cells was exposed to 0.15 to 0.6 mM of MTZ (around 25 to 100 µg/ml)
in fresh medium (without serum and antibiotics) for 3 h at 37°C,
by using 10-ml polystyrene screw-cap vials. Control experiments were
performed under similar experimental conditions, without the drug, in
the presence of only the drug solvent (PBS; 8 mM; pH 7.1). After
incubation, the vials were cooled at 4°C and the suspension was
centrifuged at 400 × g for 10 min. Trophozoites were washed
three times in cold PBS, and cell pellets were resuspended in 100 µl
of PBS (pH 7.1) and then processed to measure the oxygen uptake and
cellular viability.
Oxygen uptake.
Measurements of oxygen uptake were made in a
closed glass vessel (1 ml), thermostated at 37°C and provided with a
stirrer, by using a Clark-type oxygen electrode (YSI model 5331; Yellow Springs Instrument Co.). Oxygen uptake was calculated assuming an
oxygen concentration of 227 nmol/ml in the initial incubation at
37°C. To determine O2 uptake, 30 µl of each sample of
trophozoites was applied to the equilibrated system through a small pot
in the top of the vessel. With this technique, oxygen uptake rates were
calculated within 10 min of introducing the sample into the electrode
vessel. The effect of MTZ was determined by comparing respiratory rates
in control cells and in cells preexposed to the drug. The results were
expressed as O2 uptake (micromolar O2 per
minute per 106 cells) and as inhibition of O2
uptake (percentage of control).
Viability study.
Trophozoite viability was directly
determined by phase-contrast microscopy, with the live and dead cells
counted in a hemocytometer. Parasites were considered viable if they
had a characteristic pear-shaped structure, flagellar motility, normal
architecture of the ventral disc and refractory quality
(10).
The regrowth assay, based on the ability of viable G. lamblia trophozoites to multiply and grow in fresh culture medium
after being exposed to a lethal agent, has been extensively used for the determination of parasite viability (4, 6, 9, 10). Thus,
for the regrowth assay, 30 µl of each incubation was subcultivated for 48 h at 37°C in 10 ml of fresh TYI-S-33 medium supplemented with antibiotics. Subsequently, the vials were cooled at 4°C, and the
total number of parasites was determined microscopically with a
Neubauer cell-counter chamber. The initial number of viable parasites
in each sample was deduced by extrapolation from the standard curve of
G. lamblia growth according to the total number of parasites
at 48 h as previously described (4). The experiments were performed three times, and the results were expressed as the
number of viable cells and as a percentage of the control.
 |
RESULTS |
Oxygen consumption.
Oxygen uptake rates of G. lamblia trophozoites are shown in Fig.
1A. There was a positive correlation
between increasing drug concentration and decreasing O2
uptake rates of trophozoites. Oxygen uptake rates went from 3.04 µM
O2 min
1 per 106 cells in
untreated cells to 0.72 µM O2 min
1 per
106 cells with the highest concentration of MTZ (0.6 mM) in
the preincubation.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 1.
(A) Changes in oxygen uptake, after pretreatment for
3 h at 37°C with MTZ, of G. lamblia trophozoites.
Oxygen uptake ( ) was determined with an open oxygen electrode set at
227 µM oxygen. All assays were performed at 37°C. Standard errors
of the mean (vertical bars) were calculated from data in four
experiments. (B) Killing of G. lamblia trophozoites by MTZ
evaluated by the regrowth assay. The starting number of viable
parasites of each sample was obtained by extrapolation from the
standard curve of G. lamblia growth, represented by the
inset, by using the total number of cells at 48 h. Standard errors
of the mean (vertical bars) were calculated from data of four
experiments.
|
|
Viability studies.
MTZ induced loss of motility of G. lamblia trophozoites. The nonmotile trophozoites had, by
phase-contrast microscopy, a typical pear-shaped structure and
refractory quality (not shown). MTZ induced loss of cellular viability
as evaluated by regrowth assay. The initial number of viable
trophozoites in each sample (Fig. 1B) was obtained by extrapolation
from the standard curve of G. lamblia growth (inset of Fig.
1B) according to the total number of cells at 48 h.
Comparison of methods.
The dose-response curves obtained for
MTZ determined by oxygen uptake and those obtained by viability tests
(morphological and regrowth criteria) are shown in Fig.
2. These results are expressed as the
percentage of inhibition of the control. The MTZ concentrations which
inhibited oxygen uptake by 28 to 76% of trophozoites killed from 39 to
82% of trophozoites, as evaluated by the culture method, and altered
the morphology of 21 to 86% of the cells.

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 2.
Percentage of inhibition of G. lamblia
trophozoites by MTZ as determined by oxygen uptake ( ), viability
determined by culture method ( ), and viability determined by
morphological assay ( ). The IC50 determined by
O2 uptake was 0.33 mM (r = 0.98), that
determined by the culture method was 0.26 mM (r = 0.98), and that determined by the morphological assay was 0.35 mM
(r = 0.95). Standard errors of the mean (vertical bars)
were calculated from data of four experiments.
|
|
The morphological changes in trophozoites after exposure to MTZ were
correlated with the loss of viability as evaluated by
the culture
method; in both cases, similar 50% inhibitory concentrations
(IC
50s [0.35 and 0.26 mM, respectively]) were obtained.
Thus,
the MTZ concentrations which induce loss of motility also induce
loss of the ability of the trophozoites to multiply in fresh culture
medium.
The alterations in O
2 uptake rates correlate very well with
death as determined by the culture method and morphologic assay;
a
similar IC
50 (0.33 mM) was
obtained.
 |
DISCUSSION |
The optimal method for performing susceptibility studies of
G. lamblia has not been established. A reliable viability
assay is required for in vitro susceptibility studies and to screen drugs for antigiardial activity. Several drugs are currently used for
treatment of giardiasis in humans. Of these, MTZ, a nitroimidazole antibiotic, is recommended for chemotherapy of Giardia
infections and is the drug of choice in many countries.
MTZ and other 5-nitroimidazoles are selectively toxic to
Giardia. However, the killing mechanisms of these drugs have
not been studied with this parasite. By analogy with antimicrobial activity of MTZ against trichomonads and bacteria, it has been proposed
that effectors of cytotoxicity are the free nitro radicals, which are
formed during the metabolic reduction of the drug, which oxidizes DNA,
causing strand breaks and subsequent cell death (5). It has
been postulated that electrons generated by energy-yielding pathways
are transferred to the drug's nitro group by ferredoxin (18). However, neither the donors of the electrons nor the
cytotoxic intermediates and their target molecules have been identified.
The antibiotics with anaerobic activity should be compared with MTZ,
which is considered a "gold standard" antibiotic (7). Considering this finding and the clinical and epidemiological relevance
of drug resistance (1, 15, 16), we developed a new method to
study the susceptibility of G. lamblia trophozoites to MTZ.
The assay exploits the fact that G. lamblia trophozoites take up oxygen at rates comparable to those of aerobic protozoa, which
is abolished with death by MTZ. This alteration in metabolic activity,
induced by MTZ, was compared with cellular viability measured by
morphological criteria and the culture method.
Considering our results, showing the high correlation between oxygen
uptake rates by trophozoites and cellular viability, we can conclude
that the oxygen uptake of G. lamblia trophozoites could be
used as an index of cellular viability. This conclusion may have
additional implications with regard to characterizing the killing
mechanisms of MTZ. Recent studies have shown that NADH oxidase is
responsible for the oxygen uptake of Giardia trophozoites and may be involved in the maintenance of an optimum intracellular redox ratio (3). Oxygen uptake alteration, induced by MTZ, could be correlated with cytotoxicity mechanisms. Drug concentrations that altered O2 uptake rates induced death of trophozoites,
suggesting a link between metabolic activity and MTZ action.
Considerable differences in vitro sensitivity have been found according
to the assay employed, which may reflect different modes of action of
antigiardial drugs. Based on our data and the fact that MTZ is cidal in
its activity, it is reasonable to accept that O2 uptake
rates can be used as a convenient method to study the lethal
(irreversible drug effects) drug's activity. Our preliminary studies
showed that furazolidone was two to three times more active than MTZ
and that quinacrine was less active than MTZ (not shown); these results
were consistent with previously published values (15).
The methodology described in this study, based on the oxygen uptake of
trophozoites, is a quantitative, rapid, and simple method for the
assessment of the lethal effects of MTZ in G. lamblia trophozoites. The method has some advantages over other methods because
it does not involve radioisotopes or complex instrumentation and the
results are available within a few hours. This assay can be applied to
assessing MTZ susceptibility in G. lamblia and can be used
to screen new antigiardial agents.
 |
ACKNOWLEDGMENT |
This work was partially supported by PRODEP II.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Couraça
dos Apóstolos, no. 51, r/c, Faculdade de Farmácia da
Universidade de Coimbra, 3030 Coimbra, Portugal. Phone: 351-39852567. Fax: 351-39852569. E-mail: mcsousa{at}ci.uc.pt.
 |
REFERENCES |
| 1.
|
Barat, L. M., and P. B. Bloland.
1997.
Drug resistance among malaria and other parasites.
Infect. Dis. Clin. N. Am.
11:969-987[Medline].
|
| 2.
|
Baveja, U. K.,
V. N. Bhatia, and D. C. Warhurst.
1998.
Giardia lamblia: in-vitro sensitivity to some chemotherapeutic agents.
J. Commun. Dis.
30:79-84[Medline].
|
| 3.
|
Brown, D. M.,
J. A. Upcroft, and P. Upcroft.
1996.
A H2O-producing NADH oxidase from the protozoan parasite Giardia duodenalis.
Eur. J. Biochem.
241:155-161[Medline].
|
| 4.
|
Cedilo-Reviera, R., and O. Muñoz.
1992.
In-vitro susceptibility of Giardia lamblia to albendazole, mebendazole and other chemotherapeutic agents.
J. Med. Microbiol.
37:221-224[Abstract/Free Full Text].
|
| 5.
|
Edwards, D. I.
1993.
Nitroimidazole drugs: action and resistance mechanism. I. Mechanism of action.
J. Antimicrob. Chemother.
31:9-20[Free Full Text].
|
| 6.
|
Farbey, M. D.,
J. A. Reynoldson, and R. C. A. Thompson.
1995.
In vitro drug susceptibility of 29 isolates of Giardia duodenalis from humans as assessed by an adhesion assay.
Int. J. Parasitol.
25:593-599[Medline].
|
| 7.
|
Freeman, C. D.,
N. E. Klutman, and K. C. Lamp.
1997.
Metronidazole. A therapeutic review and update.
Drugs
54:679-708[Medline].
|
| 8.
|
Gillin, F. D., and L. S. Diamond.
1980.
Clonal growth of Giardia lamblia trophozoites in a semisolid agarose medium.
J. Parasitol.
66:350-352[Medline].
|
| 9.
|
Hemphill, S.,
B. Gottstein, and N. Muller.
1996.
Electron microscopical investigation of surface alterations on Giardia lamblia trophozoites after exposure to a cytotoxic monoclonal antibody.
Parasitol. Res.
82:206-210[Medline].
|
| 10.
|
Hill, D. R.,
R. Pohl, and R. D. Pearson.
1986.
Giardia lamblia: a culture method for determining parasite viability.
Am. J. Trop. Med. Hyg.
35:1129-1133.
|
| 11.
|
Inge, M. P. G., and M. J. G. Farthing.
1987.
A radiometric assay for antigiardial drugs.
Trans. R. Soc. Trop. Med. Hyg.
77:487-488.
|
| 12.
|
Jarrol, E. L.,
P. Manning,
A. Berrade,
D. Hare, and D. G. Lindmark.
1989.
Biochemistry and metabolism of Giardia.
J. Protozool.
36:190-197[Medline].
|
| 13.
|
Jokipii, L., and A. M. M. Jokipii.
1980.
In vitro susceptibility of Giardia lamblia trophozoites to metronidazole and tinidazole.
J. Infect. Dis.
141:317-325[Medline].
|
| 14.
|
Keister, D. B.
1983.
Axenic culture of Giardia lamblia in TYI-S-33 medium supplemented with bile.
Trans. R. Soc. Trop. Med. Hyg.
77:487-488[Medline].
|
| 15.
|
Kulda, J., and E. Nohyhová.
1995.
Therapy of giardiasis, p. 369-381.
In
J. P. Kreier (ed.), Parasitic protozoa. Academic Press, New York, N.Y
|
| 16.
|
MacIntyre, P.,
P. F. L. Boreham,
R. E. Phillips, and R. W. Shepherd.
1986.
Chemotherapy in giardiasis: clinical responses and in vitro drug sensitivity of human isolates in axenic culture.
J. Pediatr.
108:1005-1010[Medline].
|
| 17.
|
Paget, T. A.,
P. T. Macechho, and E. L. Jarrol.
1998.
Metabolic changes in Giardia intestinalis during differentiation.
J. Parasitol.
84:222-226[Medline].
|
| 18.
|
Townson, S. M.,
P. F. L. Boreham,
P. Upcroft, and J. A. Upcroft.
1994.
Resistance to the nitroheterocyclic drugs.
Acta Trop.
56:173-194[Medline].
|
| 19.
|
Zaat, J. O.,
T. G. Mank, and W. J. Assendelf.
1997.
A systematic review on the treatment of giardiasis.
Trop. Med. Int. Health
2:63-82[Medline].
|
Antimicrobial Agents and Chemotherapy, December 1999, p. 2939-2942, Vol. 43, No. 12
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Arguello-Garcia, R., Cruz-Soto, M., Romero-Montoya, L., Ortega-Pierres, G.
(2004). Variability and variation in drug susceptibility among Giardia duodenalis isolates and clones exposed to 5-nitroimidazoles and benzimidazoles in vitro. J Antimicrob Chemother
54: 711-721
[Abstract]
[Full Text]
-
Gardner, T. B., Hill, D. R.
(2001). Treatment of Giardiasis. Clin. Microbiol. Rev.
14: 114-128
[Abstract]
[Full Text]